Continual-G® Team Announces New Placement in AlchePharma Naturals
The Cellular Health Brand Lands a
"We are excited to have our products in
Continual-G® represents a hallmark evolution in the development of cellular health supplementation. Traditional glutathione supplements often come up short, flooding the body and bloodstream with the master antioxidant, but failing to get it into the cells where it is needed to improve bodily function and health. Continual-G®'s flagship ingredient, Glyteine®, consists of the immediate precursor to glutathione, gamma-glutamylcysteine (GGC). This clinically proven bioavailable form of GGC is able to infiltrate cells, giving them the tools they need to manufacture natural glutathione on their own.
Continual-G® began expanding into brick-and-mortar stores in late 2025. The new placement is with a prestigious retailer that operates a chain of health and wellness stores in
About Continual-G®
Continual-G® is a brand of the dietary development firm Inid Research Lab, LLC. Launched in 2019, the global company focuses on the mission of developing dietary supplements that incorporate Glyteine®. This proprietary ingredient is a unique approach to cellular glutathione that provides the body with the tools necessary to increase its natural glutathione production. This critical difference has helped Continual-G® stand out, both in clinical studies and through customer feedback. Learn more about the benefits and backstory of this breakthrough nutraceutical ingredient at continualg.com.
Media Contact:
832-953-2791
[email protected]
View original content:https://www.prnewswire.com/news-releases/continual-g-team-announces-new-placement-in-alchepharma-naturals-302677269.html
SOURCE Continual-G
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Thryv Therapeutics Licenses a New Class of SGK1 Inhibitors from Spain's CSIC and Universidad Autónoma de Madrid, Extending Its Platform into Neurodegenerative Disease
- Adobe Announces Anil Chakravarthy to Become President and CEO and Shantanu Narayen to Become Executive Chair on December 1, 2026
- Centerspace Announces Quarterly Dividend
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share